Matthew Hershenhorn

Stock Analyst at Oppenheimer

(3.11)

# 2,574

Out of 5,043 analysts

Total ratings

66.7%

Success rate

76.7%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Hershenhorn

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AXSM Axsome Therapeutics	Reiterated: Buy	$250 → $280	$168.35	+66.32%	7	Oct 6, 2026
	ACAD Acadia Pharmaceuticals	Reiterated: Hold	$23 → $25	$19.78	+26.39%	7	Aug 5, 2026

Axsome Therapeutics

Oct 6, 2026

Reiterated: Buy

Price Target: $250 → $280

Current: $168.35

Upside: +66.32%

Acadia Pharmaceuticals

Aug 5, 2026

Reiterated: Hold

Price Target: $23 → $25

Current: $19.78

Upside: +26.39%